92 transactions by 15 insiders, from August 4, 2026 to August 6, 2026.
People inside the company. What they do with their own shares is the reason this data exists.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| Colin WalshDir | 29 | — | $10.3M | $2.3M |
| Attovia Therapeutics, Inc.CEO | 2 | — | — | — |
| Zaneta OdrowazChief | 1 | — | — | — |
| Petter VeibyChief | 1 | — | — | — |
| Tao FuCEO | 1 | — | — | — |
| Hubert ChenCMO | 1 | — | — | — |
| Angie YouDir | 1 | — | — | — |
| Steven ChanCFO | 1 | — | — | — |
| Mitchell GoldDir | 1 | — | — | — |
Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INCOther | 29 | — | $10.3M | $2.3M |
| Frazier Life Sciences XI, L.P.10% | 9 | — | $10.0M | — |
| venBio Global Strategic Fund IV, L.P.10% | 7 | — | $6.5M | — |
| Redmile Group, LLC10% | 4 | — | $10.2M | — |
| Sanofi10% | 3 | — | $5.1M | — |
| Deep Track Biotechnology Master Fund, Ltd.10% | 2 | — | — | — |
92 in total, newest filings first.
| Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|
| Tao FuCEODERIV4/A | Aug 4 | A | 538,300 | $0.00 | —? |
| Steven ChanCFODERIV4/A | Aug 4 | A | 140,000 | $0.00 | —? |
| Colin WalshDirDERIV | Aug 6 | C | 4,445,275 | $0.00 | —? |
| Colin WalshDirDERIV | Aug 6 | C | 18,181,830 | $0.00 | —? |
| Colin WalshDir | Aug 6 | P | 500,000 | $17.00 | $8.5M |
| Colin WalshDir | Aug 6 | C | 478,498 | $0.00 | — |
| Colin WalshDir | Aug 6 | C | 1,957,134 | $0.00 | — |
| Colin WalshDir | Aug 5 | S | 76,418 | $21.04 | $1.6M |
| Colin WalshDir | Aug 5 | S | 6,763 | $21.61 | $146K |
| Colin WalshDir | Aug 5 | S | 100 | $21.99 | $2K |
| Colin WalshDir | Aug 5 | S | 1,163 | $22.19 | $26K |
| Colin WalshDir | Aug 5 | S | 700 | $22.07 | $15K |
| Colin WalshDir | Aug 5 | S | 200 | $22.05 | $4K |
| Colin WalshDir | Aug 5 | S | 443 | $21.78 | $10K |
| Colin WalshDir | Aug 5 | S | 300 | $20.84 | $6K |
| Colin WalshDir | Aug 5 | S | 1,040 | $22.05 | $23K |
| Colin WalshDir | Aug 5 | S | 1,180 | $21.84 | $26K |
| Colin WalshDir | Aug 5 | S | 400 | $22.02 | $9K |
| Colin WalshDir | Aug 5 | S | 6,970 | $22.03 | $154K |
| Colin WalshDir | Aug 5 | S | 672 | $22.02 | $15K |
| Colin WalshDir | Aug 5 | S | 753 | $21.97 | $17K |
| Colin WalshDir | Aug 5 | S | 100 | $22.11 | $2K |
| Colin WalshDir | Aug 5 | S | 480 | $21.55 | $10K |
| Colin WalshDir | Aug 5 | S | 200 | $22.10 | $4K |
| Colin WalshDir | Aug 5 | S | 3,402 | $22.02 | $75K |
| Colin WalshDir | Aug 5 | S | 1,556 | $22.06 | $34K |
| Colin WalshDir | Aug 5 | S | 200 | $22.05 | $4K |
| Colin WalshDir | Aug 5 | S | 1,332 | $22.03 | $29K |
| Colin WalshDir | Aug 5 | S | 447 | $21.87 | $10K |
| Colin WalshDir | Aug 5 | S | 988 | $22.03 | $22K |
| Colin WalshDir | Aug 5 | P | 85,000 | $21.00 | $1.8M |
| GOLDMAN SACHS GROUP INCOtherDERIVJOINT | Aug 6 | C | 4,445,275 | $0.00 | —? |
| GOLDMAN SACHS GROUP INCOtherDERIVJOINT | Aug 6 | C | 18,181,830 | $0.00 | —? |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 6 | P | 500,000 | $17.00 | $8.5M |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 6 | C | 478,498 | $0.00 | — |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 6 | C | 1,957,134 | $0.00 | — |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 76,418 | $21.04 | $1.6M |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 6,763 | $21.61 | $146K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 100 | $21.99 | $2K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 1,163 | $22.19 | $26K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 700 | $22.07 | $15K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 200 | $22.05 | $4K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 443 | $21.78 | $10K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 300 | $20.84 | $6K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 1,040 | $22.05 | $23K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 1,180 | $21.84 | $26K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 400 | $22.02 | $9K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 6,970 | $22.03 | $154K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 672 | $22.02 | $15K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 753 | $21.97 | $17K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 100 | $22.11 | $2K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 480 | $21.55 | $10K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 200 | $22.10 | $4K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 3,402 | $22.02 | $75K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 1,556 | $22.06 | $34K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 200 | $22.05 | $4K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 1,332 | $22.03 | $29K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 447 | $21.87 | $10K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | S | 988 | $22.03 | $22K |
| GOLDMAN SACHS GROUP INCOtherJOINT | Aug 5 | P | 85,000 | $21.00 | $1.8M |
| Deep Track Biotechnology Master Fund, Ltd.10%DERIVJOINT | Aug 6 | C | 18,181,818 | $0.00 | —? |
| Deep Track Biotechnology Master Fund, Ltd.10%JOINT | Aug 6 | C | 1,957,138 | — | — |
| venBio Global Strategic Fund IV, L.P.10%DERIV | Aug 6 | C | 6,179,219 | $0.00 | —? |
| venBio Global Strategic Fund IV, L.P.10%DERIV | Aug 6 | C | 7,636,362 | $0.00 | —? |
| venBio Global Strategic Fund IV, L.P.10%DERIV | Aug 6 | C | 21,477,273 | $0.00 | —? |
| venBio Global Strategic Fund IV, L.P.10% | Aug 6 | P | 382,352 | $17.00 | $6.5M |
| venBio Global Strategic Fund IV, L.P.10% | Aug 6 | C | 665,147 | — | — |
| venBio Global Strategic Fund IV, L.P.10% | Aug 6 | C | 821,998 | — | — |
| venBio Global Strategic Fund IV, L.P.10% | Aug 6 | C | 2,311,870 | — | — |
| Sanofi10%DERIV | Aug 6 | C | 782,855 | — | — |
| Sanofi10% | Aug 6 | P | 300,000 | $17.00 | $5.1M |
| Sanofi10% | Aug 6 | C | 782,855 | — | — |
| Redmile Group, LLC10%DERIVJOINT | Aug 6 | C | 782,854 | — | — |
| Redmile Group, LLC10%JOINT | Aug 6 | P | 400,000 | $17.00 | $6.8M |
| Redmile Group, LLC10%JOINT | Aug 6 | P | 200,000 | $17.00 | $3.4M |
| Redmile Group, LLC10%JOINT | Aug 6 | C | 782,854 | — | — |
| Hubert ChenCMODERIV | Aug 4 | A | 140,000 | $0.00 | —? |
| Petter VeibyChiefDERIV | Aug 4 | A | 140,000 | $0.00 | —? |
| Zaneta OdrowazChiefDERIV | Aug 4 | A | 140,000 | $0.00 | —? |
| Mitchell GoldDirDERIV | Aug 4 | A | 27,000 | $0.00 | —? |
| Frazier Life Sciences XI, L.P.10%DERIVJOINT | Aug 6 | C | 8,930,685 | $0.00 | —? |
| Frazier Life Sciences XI, L.P.10%DERIVJOINT | Aug 6 | C | 11,054,544 | $0.00 | —? |
| Frazier Life Sciences XI, L.P.10%DERIVJOINT | Aug 6 | C | 14,772,727 | $0.00 | —? |
| Frazier Life Sciences XI, L.P.10%DERIVJOINT | Aug 6 | C | 16,250,000 | $0.00 | —? |
| Frazier Life Sciences XI, L.P.10%JOINT | Aug 6 | P | 588,235 | $17.00 | $10.0M |
| Frazier Life Sciences XI, L.P.10%JOINT | Aug 6 | C | 961,322 | — | — |
| Frazier Life Sciences XI, L.P.10%JOINT | Aug 6 | C | 1,189,940 | — | — |
| Frazier Life Sciences XI, L.P.10%JOINT | Aug 6 | C | 1,590,175 | — | — |
| Frazier Life Sciences XI, L.P.10%JOINT | Aug 6 | C | 1,749,192 | — | — |
| Angie YouDirDERIV | Aug 4 | A | 27,000 | $0.00 | —? |
| Attovia Therapeutics, Inc.CFODERIV | Aug 4 | A | 140,000 | $0.00 | —? |
| Attovia Therapeutics, Inc.CEODERIV | Aug 4 | A | 538,300 | $0.00 | —? |